Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Follow-Up Questions
Who is the CEO of Ampio Pharmaceuticals Inc?
Mr. Michael Martino is the Chief Executive Officer of Ampio Pharmaceuticals Inc, joining the firm since 2021.
What is the price performance of AMPE stock?
The current price of AMPE is $0.0027, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ampio Pharmaceuticals Inc?
Ampio Pharmaceuticals Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Ampio Pharmaceuticals Inc market cap?
Ampio Pharmaceuticals Inc's current market cap is $3078
Is Ampio Pharmaceuticals Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Ampio Pharmaceuticals Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell
